Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
  • C12N15/09—Recombinant DNA-technology
  • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
  • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
  • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
  • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
  • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
  • C12N15/8205—Agrobacterium mediated transformation
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
  • A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
  • A01H4/005—Methods for micropropagation; Vegetative plant propagation using cell or tissue culture techniques

Definitions

• This invention relates to the genetic modification of Eucalyptus/ primarily for the commercial production of wood and wood products.
• the overall efficiency of genetic modification of plants is a function of the efficiency of the stable introduction of the heterologous or homologous DNA into cells, which is itself dependent on cell type and the method of transformation used, the efficiency of enrichment of transformed cells and tissues and the efficiency of the subsequent regeneration of viable plants from transformed cells.
• the specific strategies and methods that may be employed to achieve genetic modification are influenced by the biological properties and attributes of the plant involved. For example, during the development of transformation methods for any particular plant, the method of DNA delivery is preferably chosen so that DNA is introduced efficiently into cells that are totipotent and hence have the capacity for subsequent regeneration into viable plants.
• the methods developed may not be relevant to other plants because, for example, the efficiency of stable introduction of DNA and/or the totipotency of the target cells and/or and the tissue culture techniques required to express that totipotentency may be different.
• sources of starting material having juvenile characteristics may be obtained by subjecting a mature tree to physical damage, chemical agents or a change in environmental conditions in order to induce the production of juvenile shoots
• the cells and tissues of such shoots have different properties from those of young seedlings and are often less susceptible to transformation by Agrobacterium and/or are more recalcitrant to regeneration.
• Field trials of juvenile genetically modified Eucalyptus plants involve a number of disadvantages. For example. Eucalyptus trees having superior properties cannot be selected on phenotype until marked changes m the Eucalyptus morphology and physiology have occurred. These changes, from a juvenile to a mature state, can take up to 3-4 years to materialise. The mature state is characterised by the ability of the Eucalyptus to produce flower buds and seeds. In order to select trees having superior wood properties, not only must the juvenile/mature phase-change have occurred, but also a sufficient amount of mature wood must be produced. This results in extended field-triallmg periods being necessary.
• the resulting progeny of any sexual crosses may also have to be field-trialled after each step of the breeding programme.
• clonal Eucalyptus plantations that is to say, plantations of genetically identical trees, that are selected on the basis of one or a number of superior phenotypic properties after the identification of those properties in an individual within a population of trees.
• the population may be a natural population or a superior population derived by traditional breeding techniques or by genetic modification.
• Suitable material for clonal propagation can be removed from selected tree(s) having superior properties. The process of clonal propagation is repeated serially until there is sufficient cloned material to enable a plantation to be established.
• trees that have been field-trialled and identified as having superior properties are the product of a significant investment of effort in breeding and selection. Such trees therefore represent a valuable asset that can be exploited rapidly without the need for further plant-breeding steps as the trees can be propagated directly by the rooting of cuttings or by the techniques of micropropagation, and used as the planting stock for the establishment of commercial forests.
• the ability to introduce heterologous and/or homologous gene(s) into the cells and tissues of selected field-trialled trees would therefore allow additional commercially significant properties to be introduced into those already valuable trees and hence facilitate the commercial exploitation of the resulting trees in clonal Eucalyptus forests.
• the present invention provides a process for producing genetically modified Eucalyptus plant material comprising one or more stably incorporated DNA sequences of interest, which comprises subjecting
• the NPTII gene is preferably used as a selective marker gene, and selection of the transformed material may be carried out using G418, which is also known as geneticin, or neomycin.
• the resulting selected transformed plant material for example, transformed callus, regenerating shoots or regenerated shoots, may be grown into plants directly or may be propagated vegetatively, especially by micropropagation, to increase stock before being grown into plants.
• Resulting genetically modified plants may themselves be cloned, for example, by micro ⁇ propagation, or by any other method of vegetative propagation, for example, by cuttings.
• cells and tissue derived via vegetative propagation i.e. clonal material, especially clonal material from mature Eucalyptus trees exhibiting superior phenotypic properties, for example, E ⁇ grandis, E. saligna, E. dunnii or E.
• camaldulensis trees or trees that are hybrids thereof may be modified genetically and regenerated into viable plants.
• the process of the present invention may also be applied to cells and tissue derived from Eucalyptus seedlings, and enables the production of viable, genetically modified plants from seedlings of species of Eucalyptus that have previously proved recalcitrant to genetic manipulation, for example, E _ globulus, E. nitens and E_ ; _ dunnii.
• Mature Eucalyptus trees obtained from plant material modified genetically according to the present invention and products obtained from such trees, for example, timber, wood pulp and fuel wood, are valuable commercial commodities.
• cells or tissue are cultured, in a suitable medium, with Agrobacterium cells capable of delivering one or more DNA sequence (s) of interest that are functional in plants, and that can be transferred to the cells or tissue.
• a DNA sequence of interest may be heterologous to the Eucalyptus or homologous.
• suitable DNA sequences are known.
• the DNA may function to impart to the Eucalyptus a phenotypic property, e.g. resistance to a herbicide such as glyphosate, to modify wood fibre quality or the chemical components of wood, to modify rooting ability of vegetative propagules, for example, cuttings, to modify tree architecture and branching, or to induce sterility.
• Suitable media and conditions for plant culture are known. Optimal media and culture conditions for any particular starting material may be determined by routine methods if they are not already known.
• the medium may contain glutamate and/or ascorbic acid, in order to promote regeneration of shoots at high efficiency.
• the starting pH may be 5.0-5.6.
• the induction of shoot formation and the selection of transformed material according to the present invention are preferably carried out by culture on a solid medium or using another static culture medium. Examples of media suitable for use in the process of the present invention for inducing shoot formation, for selection of transformed cells and tissue and for multiplication and inducing root formation of genetically modified Eucalyptus are given herein.
• the substituted phenylurea N- (2-chloro-4-pyridyl) - N'- phenylurea is incorporated into the culture medium used for shoot induction and preferably also in the medium used for selection of transformed shoots, and also for shoot regeneration, either as the sole cytokinin or with other cytokines.
• CPPU induces bud formation in Eucalyptus at high frequency and, unlike some other phytohormones and plant growth factors, a further effect is that the buds produced are capable of further development into shoots.
• Other substituted phenylureas may be used instead of or in addition to CPPU provided they are capable of inducing, at high frequency, the formation of buds that are capable of further development.
• the suitability of any particular substituted phenylurea for any particular Eucalyptus starting material and appropriate concentrations of the selected phenylurea and regimes for its use may be determined by routine methods.
• NPTII gene may be used as the marker gene and the resistance to a phytotoxic agent conferred by that gene, for example, resistance to G-418 (also known as geneticin) or to neomycin may be used as the characteristic for selection of transformed cells or tissue. Any other DNA sequence that confers the same or similar resistance may be used as the selectable marker.
• the selective agent should be used in a concentration and in a regime that enables selection of the transformed material, for example, transformed callus, transforming shoots and transformed shoots.
• the cells or tissue used as starting material for genetic modification according to the present invention may be derived from seedlings, especially young seedlings.
• the process of the present invention is particularly useful for the genetic modification of cells and tissue obtained from E ⁇ globulus, E. nitens and E_ ⁇ dunnn seedlings, as no such process has been disclosed previously.
• cell or tissue clonal material that is vegetatively derived, directly or indirectly, from vegetative tissues of trees, especially mature trees, that have been selected, or are selectable, for favourable characteristics.
• the cell or tissue material may be obtained directly from a plant grown in the field or a greenhouse; it may be used in non-sterile form, i.e. without the use of an intervening micropropagation step, for the introduction of heterologous (or homologous) gene(s) .
• the cells or tissue may be derived indirectly from selected trees, that is to say, the cells or tissue taken from the selected tree is subjected to micropropagation before genetic manipulation.
• the tissue may be leaves, stems or petioles.
• the starting material is preferably obtained from E ⁇ grandis, E. dunnii, E. saligna or E_ ; _ camaldulensis, or from a variety, cultivar or hybrid thereof.
• Any suitable Agrobacterium vector may be used to mediate genetic modification of the Eucalyptus material.
• the Agrobacterium tumefaciens strain used to transform E_ ; _ globulus and E_ ; _ nitens seedlings, E. grandis clones and E ⁇ grandis/E. camaldulensis hybrid clones as described in the Examples is the disarmed strain EHA101A containing the binary Ti plasmid pSCVl.6. That strain may be used for the transformation of other Eucalyptus.
• Suitable binary Agrobacterium-Ti plasmid vector systems have been fully described elsewhere, e.g. in EP-A-0120516.
• Figure 1 of the accompanying drawings is a map of a plasmid identified herein as pSCVl, which is used in the production of plasmid pSCVl.6.
• Figure 2 is a map showing the T-DNA of a plasmid identified herein as pSCVl.6, which may be used in the process of the present invention.
• Amp R and Gm/KmR denote antibiotic resistance genes for plasmid selection in bacteria.
• trfA, trfB, RK2 and Col El origins denote baterial replication functions.
• OD denotes an overdrive (T-DNA transfer enhancer) sequence.
• Bam HI, Bel 1, Cla 1 etc denote restriction endonuclease recognition sequences. Map units are given in Kilo base pairs of nucleotide sequence.
• a ⁇ tumefaciens strain EHAIOI has been described by Hood et al . , 1986.
• the strain consists of a derivative of the of nopaline A. tumefaciens strain C58 in which the native Ti plasmid has been removed and replaced with the disarmed Ti plasmid pEHAlOl in which the wild-type T-DNA (ie opine synthesis and phytohormone genes) has been deleted from the Ti plasmid and replaced with a bacterially-xpressed kanamycin/neomycin resistance gene.
• the disarmed plasmid pEHAlOl is a derivative of the wild-type Ti plasmid pTiBo542 isolated from A ⁇ tumefaciens strain Bo542 (AT4) which is a L,L-succinamopine producing strain (Hood et al., 1986) .
• Strain EHA101A is a chloramphenicol resistant mutant of strain EHAlOl which was isolated by Olszwelski et al . , 1988.
• Binary vector construct
• the strain used in the transformation also contains the binary Ti plasmid pSCV1.6, which is a derivative of pSCVl . Genetic manipulations involving these plasmids were performed using standard techniques (Sambrook et al., 1989) .
• the component parts of pSCVl are derived from the following (gram-negative) plasmids: the sequence used for the right DNA border and overdrive sequence was synthesised using sequence information from from the TL right border of the octopine Ti plasmid pTiA6 (Peralta et al., 1986) .
• the left border was synthesised using sequence information from the TL of the same Ti-plasmid (Simpson et al., 1982) and is identical to the TL left border of the octopine plasmid pTiACH5 (Holsters et al . , 1983) .
• Octopine-type border sequences were used as these have been shown to promote more efficient tumour formation when used in conjunction with the hypervirulent strain EHAlOl (Hood et al. , 1986) .
• the 97bp polylinker containing restriction enzyme sites for cloning genes into the T-DNA was derived from pUC19 (Yannish-Perron et al., 1985) .
• the high copy number origin of replication which is active in E ⁇ coli cells but not Agrobacterium cells was derived from pUC19 (Yannish-Perron et al. , 1985) .
• the origin of replication of pUC 19 which was itself originally derived from the plasmid ColEl, a plasmid isolated from E. coli .
• the actual pUC sequence used has been extensively deleted to remove some non-functional (superfluous) DNA sequences.
• the low copy number origin of replication which is active in both E. coli cells and Agrobacterium cells was derived from the the broad host-range Inc P plasmid RK2.
• the origin used is a minimal 4.3kb origin which was constructed by deleting most of the non-functional sequences originally present in the wild-type RK2 plasmid (Thomas et al., 1980) .
• the minimal origin therefore contains only two genes (trf A and trf B) and associated non-coding sequences needed for replication in bacteria.
• the bacterially-expressed gentamicin/kana- mycin resistance gene was derived from the plasmid pSa (Edwards, 1988) and is probably an aminoglycoside acetylase (Valant e and Kato, 1989) . It has no apparent homology to the neomycin phosphotransferase II coding region (Edwards, 1988) .
• the bacterially- expressed ampicillm/carbenicillin resistance ( ⁇ -lactamase, bla) gene was cloned from pUC19 (Yannish-Perron et al., 1985) .
• a genetic and restriction map of pSCVl is shown in Figure 1.
• Amp R and Gm/K R denote antibiotic resistance genes for plasmid selection in bacteria.
• trfA, trfB, RK2 and Col El origins denote baterial replication functions.
• OD denotes an overdrive (T-DNA transfer enhancer) sequence.
• Bam HI, Bel 1, Cla 1 etc denote restriction endonuclease recognition sequences. Map units are given in Kilo base pairs of nucleotide sequence.
• pSCVl .6 is a derivative of pSCVl, into which a plantexpressed ⁇ -glucuronidase (GUS) gene and a plant-expressed kanamycin resistance gene were cloned between the T-DNA borders.
• GUS ⁇ -glucuronidase
• the CaMV-NPTII was derived from the construct of Fromm et al., 1986. However, it has been reported that several of the most common NPTII genes used in plant genetic-manipulation encode a mutant enzyme that has a reduced ability to detoxify kanamycin (Yenofsky et al., 1990). The mutation involves a single base change, resulting in the replacement of a glutamic acid residue by an aspartic acid at the active site of the neomycin phospho- transferase (NPTII) enzyme (originally isolated from the bacterial transposon Tn5) . While the stability of the m-RNA and the protein appeared unaffected by the mutation, the enzyme activity towards kanamycin is significantly reduced.
• the presence of the mutation in a gene can be identified by checking for the loss of a site for the restriction endonuclease XhoII in the NPTII coding sequence.
• This mutation was found to be present in the CaMV-NPTII gene of Fromm et al., 1986 and was repaired in the following manner.
• the plasmid pSUP2021 (Simon et al, 1983) is approximately lOkb in size and includes a complete copy of the transposon Tn5. Digestion of this plasmid with Pst 1 and Sma 1 gives a 788bp fragment that extends from position 1730 to 2518 within Tn5 (Beck et al., 1982).
• This fragment was isolated and restricted with Sph 1 (giving fragments of 352 and 436 bp) or XhoII (giving fragments of 120, 246, 394 and 28 bp) , and is therefore "wild-type" with respect to the mutation at position 2096.
• the Pst 1/Sma 1 fragment was subcloned into Pst 1/Sma 1 cut pUC19 to give pTn5sub. This was then digested with Sma 1 and ligated with 8mer phosphorylated Bam HI linkers.
• a clone in which the Sma 1 site had been converted to a Bam HI site was then digested with Sph 1 and Bam HI and the 436bp fragment (from position 2082 to 2518) isolated. This was used in a tripartite ligation with the 542 bp Bam HI/Sph 1 fragment from pCaMVNeo (positions 1540 to 2082) and Bam HI digested pUC19. Recombinant's were restricted with Bam HI and Sph 1 to ensure that they contained both the 436 and 542 Bam Hl/Sph 1 fragments, and Xho II to confirm that the site at position 2096 had been restored.
• This construct has a Bam HI fragment which contains the NPTII gene coding sequence which is essentially identical to the Bam HI fragment used by Fromm et al., (1986) to make pCaMVNeo, except that the mutation has been corrected.
• This construct was designated pneoNeo.
• the Bam HI insert of pneoNeo containing the NPTII coding sequence was then isolated and religated with the large (approx. 3 kb) fragment isolated from Bam HI restricted pCaMVNeo, this fragment containing the vector plus CaMV promoter and nopal e synthase gene 3' termination sequence.
• pCaMVNeo Recombmants were checked against pCaMVNeo for the correct orientation using both Pvu II (2 sites) or Eco Rl/Sph 1 (both unique), giving pCaMVneoNeo. This was again checked for the correct number of Xho II sites.
• the Hind III fragment from pCaMVneoNeo containing the restored plant-expressed kanamycin resistance gene was cloned into the Hind III site of pSCVl to give the plasmid pSCV1.2.
• pSCV1.2 was partially digested with HindiII and the linear 10.2kb product isolated.
• Seedlots of E. globulus collected from Curanilahue, Chile were obtained from Forestal Y Agricola Monte Aguila, Nacimiento, Chile. Seeds of E ⁇ nitens provenance Errinundra S.F. were obtained from CSIRO Division of Forestry, Australian Tree Seed Centre,
• E. globulus except that germination was conducted at 16° C prior to the transfer to the 23°C growth room for subsequent growth of the seedlings as described for E. globulus.
• Hypocotyls were prepared from 8-26 day-old E. globulus and E ⁇ nitens seedlings and explants 2.5-5mm long were excised from the apical end (upper one third) of the hypocotyl. The hypocotyl explants were transferred to liquid seedling shoot induction medium (see later) until required.
• the liquid medium contains the same constituents as the solid medium except that the phytagel is omitted, c) Preparation of Agrobacterium inoculum
• the cells were harvested by centrifugation at 6000g for 10 minutes, resuspended in 2mM MgS04 and repelletted. The cells were washed once more in 2mM MgS ⁇ and once in liquid clone co-cultivation medium (see later) . The cells were finally resuspended in liquid clone co-cultivation medium and diluted to a density of 10 9 cells ml—1 ready for co-cultivation with the explants. d) . Inoculation of explants with Agrobacterium and regeneration of putative transgenic shoots Hypocotyl explants were incubated with the Agrobacterium suspension, prepared as described above, for 15 minutes in a sterile 9 cm petri dish.
• the dish was placed on an orbital shaker and shaken gently at 23 c C during the incubation. After incubation, excess bacterial suspension was removed from the explants by blotting with filter papers and the hypocotyl explants were transferred to solid seedling shoot induction medium (half-strength macroelements and iron as described by Murashige and Skoog (1962), microelements as described by Bourgin and Nitsch (1967), vitamins as described by Nitsch and Nitsch (1965), 30 g l -1 sucrose, 1 mg 1 _1 CPPU (N- (2-chloro-4-pyridyl) -N 1 - phenylurea), 0.1 mg 1 NAA (naphthaleneacetic acid), pH adjusted to 5.6 with KOH) solidified with 3 g l "1 phytagel (Sigma) .
• solid seedling shoot induction medium half-strength macroelements and iron as described by Murashige and Skoog (1962), microelements
• the inoculated hypocotyls were incubated for 48 hours under the same conditions used for the germination of E. globulus seeds.
• the hypocotyl segments were then washed twice (3 hours per wash) in liquid regeneration medium containing 400 mg 1 augmentin (Beechams; SKB) at 23°C with gentle shaking. Excess liquid was then removed by blotting the explants with filter paper and the explants transferred to solid seedling shoot induction medium containing 300 mg 1 augmentin and 10 mg 1 G-418 (geneticin) .
• the hypocotyls were incubated for 4 weeks (with one subculture onto fresh medium after 2 weeks) under the same conditions used for the germination of E. globulus seeds.
• nitens micropropagation medium full strength macroelements, microelements and vitamins, as described by Murashige and Skoog (1962), 20 g 1 sucrose, 0.01 mg 1 mdole-3-butyr ⁇ c acid (IBA), 0.1 mg l -1 BAP, pH adjusted to 5.6 with KOH, 2 g l "1 phytagel) containing 300 mg 1 augmentin and propagated at 23°C using 16 hour day illumination regime
• nitens root induction medium quarter-strength macroelements and microelements as described by Murashige and Skoog (1962), 20 g l "1 sucrose, 40 mg 1 _1 IBA, pH adjusted to 5.6 with KOH, 2 g 1 phytogel) and incubating the shoots for 24h under the environmental conditions used for micropropagation.
• shoots were transferred and the stems inserted into a polypropylene fibre substrate (Milcaps, Milcap France, S.A., Chemin de Montbeau, 49340 Nuaille, France) soaked in liquid E. globulus/E.
• nitens rooting medium quarter-strength macroelements and microelements as described by Murashige and Skoog (1962), 20 g I "1 sucrose, pH adjusted to 5.6 with KOH) and incubated under the environmental conditions used for micropropagation and root induction.
• the plants When actively growing roots were visible growing through the polypropylene plug, the plants were transferred to approximately 7.5cm (3 inch) square plant pot filled with coco-peat. The plants were placed inside a mist propagator and slowly hardened off by reducing the humidity over a period of a week. After three to four weeks, the plants were transferred to approximately 17.5cm (7 inch) pots and placed in a glasshouse facility. The plants were grown under natural daylight and were watered daily.
• E. grandis clone 91/4 and E. grandis/E. camaldulensis hybrid clones 11/25 and 11/15 were supplied by the South African Forestry Research
• E ⁇ dunnii clones G7 and G14 were obtained from Mondi Forests, NTE House, P.O. Box 39, Pietermaritzburg 3200, Republic of South Africa.
• E. saligna/E. tereticornis hybrid 2.32 was obtained from Congolaise de Development Forestier, B.P 1227 Pointe Noire, Republique Du Congo. Stock plants were obtained by felling mature trees and harvesting cuttings from new growth arising from from epicormic buds in the stump.
• Leaf, petiole or stem explants from the clones were prepared directly from axenic micropropagated shoot cultures or rooted micropropagated shoots without disinfection (protocols for micropropagation and susequent rooting of shoots are given below) .
• leaf, petiole or stem explants were prepared from ramets (either produced via micropropagation or by cuttings) grown in the green ⁇ house or in the field and disinfected prior to co- cultivation with Agrobacterium tumefaciens.
• young scions with healthy leaves less than 3cm in length were harvested from the upper portion of the crown from vigorous plants of less than 1.5 metres in height, and disinfected by immersion in a 20% v/v Milton solution containing 0.1% v/v Tween 20 for 10 minutes with gentle agitation. The scions were then rinsed three times in sterile distilled water prior to dissection.
• 3-5mm diameter leaf explants or 2-4mm long sections of stem or petioles were prepared from the scions and placed in liquid clonal co-cultivation medium (see below) until required for co-cultivation with the A. tumefaciens strain.
• the explants were co-cultivated with the Agrobacterium strain for 48 h in the dark at 23°C. After incubation, excess bacterial suspension was removed from the explants by blotting with filter paper and the explants were then washed twice (3 hours per wash) in liquid clone co-cultivation medium containing 400 mg 1 augmentin at 23°C with gentle shaking. The explants were then transferred to clonal shoot induction medium (as for clone co-cultivation medium but containing 500 mg 1 glutamme, 50 mg l -1 ascorbic acid, 300 mg 1 augmentin and 30 mg l -1 G- 418.
• the explants were incubated in the dark at 23°C for 4 weeks with subculture to fresh medium after 2 weeks and at the end of the period of incubation in the dark.
• the cultures were then transferred to continuous light (40 ⁇ mol m ⁇ 2 s _1) and incubated at 23°C.
• the cultures were then subcultured every two weeks onto fresh clonal shoot induction medium until significant numbers of shoot primordia were visible.
• the explants were subcultured onto clonal shoot elongation medium (as clonal shoot induction medium) but with the CPPU ommitted, the NAA concentration adjusted to 0.112 mg 1 ⁇
• Putative genetically modified shoots were excised from the cultures and transferred to clonal shoot multiplication medium (190 mg 1 KNO3, 825 mg 1 NH4NO3, 220 mg I "1 CaCl2-H2 ⁇ , 925 mg l -1 MgS04, 85 mg 1 KH2PO4, half-strength Murashige and Skoog basal salt micronutrient solution (catalogue number M0529) , vitamins as described by Morel and Wetmore (1951), 10 g 1 sucrose, 0.04 mg l "1 BAP, 300 mg l -1 augmentin, pH adjusted to 5.6 with KOH, 2 g l "1 phytagel).
• the cultures were propagated at 23°C using a 16 hour day illumination regime (50-70 ⁇ mol m s ' .
• the multiplying shoots were divided and subcultured onto fresh clonal shoot multiplication medium at 4 weekly intervals.
• rooting medium as clonal shoot multiplication medium but with the BAP ommitted and containing 0.2 mg l- ⁇ IBA
• Shoots with developing roots were transferred to a sterile Jiffy-7 peat pellet (Jiffy Products (UK) Limited, 14/16 commercial Road, March, Cambridge, UK) in a Magenta pot (Sigma) for root establishment.
• E.dunnii seed was obtained from a specialized Forestal Oriental, 18 de Julio 818, Paysandu 6000, Brazil (seed batch reference no. 1278) .
• E. dunnii clones G7 and G14 were obtained from Mondi Forests, NTE House, P.O. Box 39, Pieterma ⁇ tzburg 3200, Republic of South Africa. Stockplants were obtained as described in Example 2. b) Seed germination and preparation of explants for transformation
• E. dunnn seeds of E. dunnn were surface sterilised as previously described for E. nitens seeds in Example 1. Disinfected seeds were germinated as previously described for E. globulus in Example 1. Hypocotyl explants for prepared as previously described for E. globulus and E. nitens in Example 1. The hypocotyls were transferred to a reservoir of liquid clonal co- cultivation medium as described in Example 2. Explants from clones were prepared as described in Example 2. c) Preparation of Agrobacterium tumefaciens inoculum
• Agrobacterium tumefaciens strain EHA101A containing the binary plasmid pSCVl .6 was prepared for inoculation of the clonal explants as has been described in xample 1 except that the final wash and subsequent resuspension of the cells was conducted in liquid clone co-cultivation medium as described in Example 2. d) Inoculation of explants with Agrobacterium and regeneration of putative transgenic shoots Inoculation of E.
• dunnn seedling and clonal explants with Agrobacterium and regeneration of putative transgenic shoots was conducted as described in Example 2 , except that selection for genetically modified shoots from seedlings was conducted on 10 mg I "1 G-418 instead of 30 mg l "1 G-418 used in Example 2. e) Multiplication and rooting of putative genetically modified shoots
• GUS Histochemical ⁇ -glucuronidase
• the petri dish was placed in a vacuum desiccator and the vessel was evacuated several times until all of the explants were submerged in the fixation solution.
• the explants were incubated for 45 minutes at room temperature and then washed twice in 50mM sodium phosphate buffer (pH 7.0) .
• the explants were then transferred into a 2mM 5-bromo-4-chloro-3-indoyl glucuronide (X-GLUC) solution made up in 50mM sodium phosphate buffer (pH 7.0) .
• the X-GLUC solution was vacuum infiltrated into the explants several times, the dish sealed with Nescofil and then incubated at 37°C overnight.
• the reaction was stopped by transferring the explants to 70% ethanol.
• GUS activity could be detected by the presence of an insoluble blue stain.
• DNA extraction was carried out as described by Keil and Griffin (1994) . 10 micrograms of DNA isolated from transformed Eucalyptus plants were digested with with Kpnl and Xbal in the appropriate restriction buffers. To aid the digestion of DNA, casein was added to the restriction mixture at a final concentration of 0.1 mg/ml (Drayer and Schulte-Holthausen, 1991) . The restrictions were carried out at 37°C overnight. Electrophoresis of the samples. Southern blotting and hybridisation were performed as described by Sambrook et al. (1989) . The plasmid pJIT65 (Gue ⁇ neau, 1990) was digested with Eco RV and the plasmid pCaMV digested with Bam HI.
• the resulting restriction fragments were separated by electrophoresis on a 1.5% agarose gel (Sambrook e_t al . , 1989) .
• a 2kb (approximately) DNA fragment containing part of the coding sequence of the GUS gene and the Cauliflower Mosaic Virus 35S gene terminator region and a 1.0 kb (approximately) DNA fragment containing the NPT2 coding sequence were eluted from the gel by the method of Heery e_t al.
• the process of the invention as described m the Examples set out above enabled transformed Eucalyptus plants to be produced efficiently and in short periods of time, even from explants originating from mature plants (clones) which had previously been grown in the field and for which production of transformed plants has not proved possible.
• the efficiency of these methods enabled large populations of plants each resulting from individual transformation events to be produced from any one of the Eucalyptus species or hybrids transformed.
• genetically modified shoots were obtained via organogenesis from genetically modified callus. In some cases, mixed organogenesis and somatic embryogenisis could be observed in some of the cultures, particulary if culture periods on regeneration media were continued for extended periods.
• viable plants were recovered that exhibited normal phenotypes when grown greenhouse conditions.
• a high proportion (in excess of 70%) of the genetically modified plants from any one of the Eucalyptus species or hybrid transformed were found to express the ⁇ - glucuronidase gene as determined by histochemical staining.
• at least 80% of the regenerated shoots were found to contain at least one of the genes from the T-DNA of pSCVl .6 integrated into the genome of the Eucalyptus species or hybrid.

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Health & Medical Sciences (AREA)
• Biotechnology (AREA)
• Genetics & Genomics (AREA)
• Biomedical Technology (AREA)
• Cell Biology (AREA)
• Organic Chemistry (AREA)
• Developmental Biology & Embryology (AREA)
• Molecular Biology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Chemical & Material Sciences (AREA)
• Zoology (AREA)
• General Engineering & Computer Science (AREA)
• Wood Science & Technology (AREA)
• Environmental Sciences (AREA)
• Microbiology (AREA)
• Plant Pathology (AREA)
• Biophysics (AREA)
• Physics & Mathematics (AREA)
• Biochemistry (AREA)
• General Health & Medical Sciences (AREA)
• Botany (AREA)
• Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=10769751

Family Applications (1)

Country Status (12)

Families Citing this family (12)

Family Cites Families (10)

• 1995
  • 1995-02-17 GB GB9503099A patent/GB2298205A/en not_active Withdrawn
• 1996
  • 1996-02-02 IL IL11702396A patent/IL117023A0/xx unknown
  • 1996-02-13 AR ARP960101362A patent/AR004935A1/es unknown
  • 1996-02-15 ZA ZA961200A patent/ZA961200B/xx unknown
  • 1996-02-16 BR BR9607723A patent/BR9607723A/pt not_active Application Discontinuation
  • 1996-02-16 AU AU49402/96A patent/AU706650B2/en not_active Ceased
  • 1996-02-16 WO PCT/EP1996/000712 patent/WO1996025504A1/en not_active Application Discontinuation
  • 1996-02-16 EP EP96905771A patent/EP0808372A1/de not_active Withdrawn
  • 1996-02-16 UY UY24168A patent/UY24168A1/es unknown
  • 1996-02-16 NZ NZ303170A patent/NZ303170A/xx unknown
  • 1996-03-12 TW TW085102966A patent/TW319679B/zh active
• 1997
  • 1997-08-14 OA OA70063A patent/OA10503A/en unknown

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events